Affimed NV (AFMD) Reaches $2.08 After 4.00% Down Move, Atlanta Capital Management Co Lifted By $3.49 Million Its Mondelez Intl (MDLZ) Stake

June 30, 2017 - By wolcottdaily

The stock of Affimed NV (NASDAQ:AFMD) is a huge mover today! About 63,270 shares traded. Affimed NV (NASDAQ:AFMD) has declined 19.09% since June 30, 2016 and is downtrending. It has underperformed by 35.79% the S&P500.The move comes after 5 months negative chart setup for the $91.02M company. It was reported on Jun, 30 by Barchart.com. We have $2.00 PT which if reached, will make NASDAQ:AFMD worth $3.64M less.

Atlanta Capital Management Co Llc increased Mondelez Intl Inc (MDLZ) stake by 4.34% reported in 2016Q4 SEC filing. Atlanta Capital Management Co Llc acquired 79,388 shares as Mondelez Intl Inc (MDLZ)’s stock rose 7.60%. The Atlanta Capital Management Co Llc holds 1.91M shares with $84.58 million value, up from 1.83 million last quarter. Mondelez Intl Inc now has $64.16B valuation. The stock rose 0.16% or $0.07 reaching $43.19 per share. About 2.38 million shares traded. Mondelez International Inc (NASDAQ:MDLZ) has risen 5.69% since June 30, 2016 and is uptrending. It has underperformed by 11.01% the S&P500.

Since February 9, 2017, it had 1 buying transaction, and 4 sales for $77.87 million activity. The insider Brusadelli Maurizio sold 1,600 shares worth $71,672. BUNCH CHARLES E had bought 2,000 shares worth $89,900 on Thursday, February 9. $269,220 worth of stock was sold by Hargrove Robin S. on Friday, May 12. PELTZ NELSON also sold $77.42M worth of Mondelez International Inc (NASDAQ:MDLZ) shares.

Atlanta Capital Management Co Llc decreased Jones Lang Lasalle Inc (NYSE:JLL) stake by 8,196 shares to 1.22M valued at $123.69M in 2016Q4. It also reduced Marsh & Mclennan Cos Inc (NYSE:MMC) stake by 45,039 shares and now owns 694,411 shares. Cdw Corp (NASDAQ:CDW) was reduced too.

Investors sentiment increased to 0.92 in 2016 Q4. Its up 0.01, from 0.91 in 2016Q3. It increased, as 60 investors sold MDLZ shares while 418 reduced holdings. 84 funds opened positions while 357 raised stakes. 1.14 billion shares or 0.77% more from 1.13 billion shares in 2016Q3 were reported. Baxter Bros holds 0.08% or 5,247 shares. Echo Street Mngmt Limited Liability Corporation reported 368,194 shares. The Georgia-based Synovus Financial has invested 0.21% in Mondelez International Inc (NASDAQ:MDLZ). Whittier holds 374,938 shares. Point72 Asset Mngmt LP accumulated 258,600 shares or 0.08% of the stock. 108,787 were reported by Princeton Portfolio Strategies Grp Inc Limited Com. Sii Invs Wi invested 0.08% in Mondelez International Inc (NASDAQ:MDLZ). Cleararc Cap holds 0.3% or 37,513 shares. 320,111 are held by 1832 Asset Mngmt Ltd Partnership. Asset Mngmt One has 2.81 million shares for 0.31% of their portfolio. Tompkins Fincl holds 846 shares or 0.01% of its portfolio. Usca Ria Lc stated it has 22,534 shares. Thornburg Mngmt Inc reported 1.35% in Mondelez International Inc (NASDAQ:MDLZ). The Michigan-based Telemus Cap Limited Liability Company has invested 0.05% in Mondelez International Inc (NASDAQ:MDLZ). Guggenheim Capital Ltd Liability Company stated it has 0.2% in Mondelez International Inc (NASDAQ:MDLZ).

Among 18 analysts covering Mondelez International Inc (NASDAQ:MDLZ), 13 have Buy rating, 1 Sell and 4 Hold. Therefore 72% are positive. Mondelez International Inc had 35 analyst reports since July 31, 2015 according to SRatingsIntel. The rating was downgraded by CLSA to “Outperform” on Thursday, August 6. RBC Capital Markets maintained Mondelez International Inc (NASDAQ:MDLZ) on Thursday, April 28 with “Outperform” rating. The rating was initiated by Buckingham Research with “Buy” on Monday, October 19. The stock has “Buy” rating by Goldman Sachs on Tuesday, April 4. On Monday, October 26 the stock rating was initiated by Susquehanna with “Positive”. The stock of Mondelez International Inc (NASDAQ:MDLZ) has “Outperform” rating given on Friday, July 31 by RBC Capital Markets. The firm has “Hold” rating given on Thursday, November 10 by Deutsche Bank. JP Morgan maintained the shares of MDLZ in report on Tuesday, September 6 with “Overweight” rating. Canaccord Genuity upgraded the shares of MDLZ in report on Thursday, February 4 to “Buy” rating. The rating was maintained by Deutsche Bank with “Buy” on Friday, July 31.

Among 7 analysts covering Affimed Therapeutics (NASDAQ:AFMD), 4 have Buy rating, 0 Sell and 3 Hold. Therefore 57% are positive. Affimed Therapeutics had 13 analyst reports since August 6, 2015 according to SRatingsIntel. The stock of Affimed NV (NASDAQ:AFMD) has “Hold” rating given on Wednesday, September 9 by Jefferies. Zacks upgraded the stock to “Hold” rating in Thursday, September 3 report. Jefferies maintained Affimed NV (NASDAQ:AFMD) on Thursday, May 19 with “Hold” rating. The rating was maintained by Oppenheimer on Thursday, August 6 with “Outperform”. The stock has “Market Perform” rating by Leerink Swann on Thursday, May 19. Wells Fargo initiated the shares of AFMD in report on Friday, December 4 with “Outperform” rating. The rating was initiated by Laidlaw on Thursday, December 10 with “Buy”. The firm earned “Market Perform” rating on Friday, August 12 by Leerink Swann. The rating was initiated by BMO Capital Markets with “Outperform” on Tuesday, April 12. The firm earned “Sell” rating on Monday, August 10 by Zacks.

Affimed N.V. is a clinical-stage biopharmaceutical firm focused on discovering and developing cancer immunotherapies. The company has market cap of $91.02 million. The Company’s product candidates are developed in the field of immuno-oncology, which represents an approach to cancer research that seeks to harness the body’s own immune system to fight tumor cells. It currently has negative earnings. The Company’s pipeline includes FM13, AFM11, AFM21, AFM22, AFM24, TandAb and Trispecific Abs.